<SEC-DOCUMENT>0001575872-24-001038.txt : 20240930
<SEC-HEADER>0001575872-24-001038.hdr.sgml : 20240930
<ACCEPTANCE-DATETIME>20240930065459
ACCESSION NUMBER:		0001575872-24-001038
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20240930
DATE AS OF CHANGE:		20240930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DR REDDYS LABORATORIES LTD
		CENTRAL INDEX KEY:			0001135951
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15182
		FILM NUMBER:		241336615

	BUSINESS ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
		BUSINESS PHONE:		91 40 49002900

	MAIL ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>drr0676_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 6-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13A-16 OR 15D-16</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDER THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">September, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number 1-15182</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">DR.
REDDY&rsquo;S LABORATORIES LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>8-2-337, Road No. 3, Banjara Hills</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hyderabad, Telangana 500 034, India</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">+91-40-49002900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form
20-F </FONT><FONT STYLE="font-family: Wingdings">x</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ______</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note:</B> Regulation S-T Rule 101(b)(1) only permits the submission
in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ______</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note: </B>Regulation S-T Rule 101(b)(7) only
permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer
must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized
(the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s securities
are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the
registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yes
</FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No </FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to registrant in connection with Rule 12g3-2(b): 82-________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXHIBITS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; width: 9%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
    of Exhibits</B></FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="drr0676_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="drr0676_ex99-1.htm" STYLE="-sec-extract: exhibit">Intimation
    dated September 30, 2024</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DR. REDDY&rsquo;S LABORATORIES LIMITED</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Registrant)</P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
                                            September 30, 2024</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ K Randhir Singh</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K Randhir Singh</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>drr0676_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 68%; padding-bottom: 8pt; font-size: 10pt"><IMG SRC="drr0676_ex99-1img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 32%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Hyderabad - 500 034, Telangana,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>India.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CIN : L85195TG1984PLC004507</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Tel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: +91 40 4900 2900</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fax&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: +91 40 4900 2999</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Email : mail@drreddys.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>www.drreddys.com</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">September 30, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">National Stock Exchange of India Ltd. (Scrip Code:
DRREDDY-EQ)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BSE Limited (Scrip Code: 500124)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York Stock Exchange Inc. (Stock Code: RDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NSE IFSC Ltd (Stock Code: DRREDDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sir/Madam,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%; text-align: left"><B>Sub:</B></TD><TD STYLE="text-align: justify; width: 95%"><B>Intimation under Regulation 30 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015- Completion of acquisition of Nicotinell&reg; and related brands</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is further to our intimation dated June 26,
2024, on the acquisition, by our wholly-owned subsidiary Dr. Reddy&rsquo;s Laboratories SA, Switzerland, of Haleon plc's global portfolio
of consumer healthcare brands in the Nicotine Replacement Therapy (&ldquo;NRT&rdquo;) category outside of the United States, through the
purchase of shares of Northstar Switzerland SARL (&ldquo;Northstar Switzerland&rdquo;), a Haleon group company. We would like to inform
you that acquisition has now been completed, and the Company has made payment of upfront cash consideration of GBP 458 million. Further,
as part of this acquisition, Northstar Switzerland along with its wholly owned subsidiaries North Star OpCo Limited (United Kingdom) and
North Star Sweden AB (Sweden) are now wholly-owned step-down subsidiaries of the Company with effect from September 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our acquired portfolio consists of Nicotinell,
a global leader in the NRT category with an extensive footprint in over 30 countries spanning Europe, Asia including Japan, and Latin
America, and local market-leading brand names of the product &ndash; Nicabate in Australia, Thrive in Canada, and Habitrol in New Zealand
and Canada. The portfolio is inclusive of all formats such as lozenge, patch, gum as well as pipeline products, in all applicable global
markets outside of the United States. Nicotinell is the second biggest brand globally (excluding the United States) in the NRT category.
NRT is recommended by the &lsquo;World Health Organization Model List of Essential Medicines&rsquo; for nicotine use disorders. The acquisition
of this global portfolio of consumer healthcare products is a significant and logical extension of the Company&rsquo;s efforts in consumer
healthcare (nutrition and OTC wellness) in recent years, and of its purpose of &lsquo;Good Health Can&rsquo;t Wait&rsquo;. The Company
has been steadily building its OTC presence in various markets and investing in its capabilities, including a recent joint venture with
Nestl&eacute; India. As a business, consumer healthcare is a growing and sustainable business with favourable long-term trends. This acquisition
is an ideal anchor to continue to build the company&rsquo;s global consumer healthcare OTC business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The details required under Regulation 30 of the
SEBI Listing Regulations, read with SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, have already been made available vide the
&lsquo;Annexure A&rsquo; of our intimation dated June 26, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is for your information and record.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanking you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For <B>Dr. Reddy&rsquo;s Laboratories Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="drr0676_ex99-1img02.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>K Randhir Singh </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Company Secretary, Compliance Officer and Head-CSR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>drr0676_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0676_ex99-1img01.jpg
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M Q$!_\0 GP   0,% 0$!              @)"@$"! 8' P4+ 0$!  ,! 0
M             0($!0,&$   !@$# P($! 4"!P$    ! @,$!08' !$($A,)
M(10Q014642(C"F&!H1<8P23P<9'1,D(E)A$  0,"! ,&!0,%         0 "
M Q$$(3$2!4%187&1L2(R$_"!H2,4P4(ST>$D%0;_V@ , P$  A$#$0 _ )_&
MB(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1<ES7G+%''?'=@RMF:[0U"
MHE;2 TC.S2XI)J.52',TBHUL0#NI:9D#)"5LT;$4<+G]"E'1L3[AWLL!JK51
MWKW^YJPE%3;EACCC7D^YP3=99-O8;-:*W3%9 A%.A%RC!HM["Z:I+%*)^E8Y
M5  Q0$H#U '<B_Y^415+J%2H2^N!OF1XV<Z+&&-&498L/YF49.'D9C^\.XIR
MA:D&A3JO"TFQQSDK6??LVR8KJLCH-W16Y3*%(H4AQ+SKFTDMR<*@(M;\LOE9
M2\?L74:%0ZDPO.<LDQ;N?AFLZX=-ZE4JDS=FC%[#/&CG:,J[D'K\#)Q[1+MI
MJ"DH<Z@%3Z3^FV;<[<O/6C0F2;\\9_G7O^:LZ5#CWRBJ=>%QE&QJPN/\G599
MQ&GAK-* _<Q-8L\,[6.S=PSPZ8,F;I R:R2IR%6*MW!.3;OMH%H/<::BB54E
M:[YNP[C28KE?R/E+']!G;>HHE5H>XV^!K<E8%$E4T% B&<N^9KO@*X5(GU)E
M$O<,!=^H0#7';#)+72"6C'!%T\ARG+U%WV_B A\@'X" #\]885T\40)A -]@
M_P"NW]1]->+9)7&@:%<%9UB8^V^WI\C /S_@.VMAH=IJX4*B]=]8:VZM/%%7
M62+'<+"B0# 43B)RDZ0.0AOS" ?EZQ #&]?_ !^(Z#')%C>Y WQ(LF&VX=PO
MQ ?P$.H-]PUF6%%GD'<A1_$H#_36"*[1%:8W243;;](;B'KOL'J.P  B([?
M/GHBP/?CT&4*W64(03 ?M="AB[>H;_F*41$HAN ".V_K\-$6:4_4D"FPAN3K
MV$ W#TWV$ $0W_GH$7@+H .0G;/^H8"$-ML01,43AN8?Q*'R ?76>G!%E .X
M;ZP1'S#1$:P+G T.2JKK-10FOW'W(2R7'E%1^.J#UZUI&'*)%7!U&=2R#&5N
M]]!PN$PJF*B9'IXB :(((G ![8KK 40$Q]?1[+&T?<(JXE%'.#7?DD<7TR"Q
M*V^@W^U8JO-0R;1I9U!W&@6*)ME;EF:ITEV4M"/$WS8Y#$,4027[8I+%WV52
M.8IO0=:\H:Z)X<T$EI\"E5+'\S?!#/?,ZG<?N8.!ZJ\O<\QP]!L+[BR%Z%[(
ME$V!LA=(Z=J;,YTPF#L7,NY;.FB0BN8G;.D"@]9 X&T7GX;?9?0-/'XP65$V
M3XX_''FNOY[Q_P D^5E56XS\=,!7*!O]CN.;W#?'Q;!8:^Z^I5>NUYE.KM73
MKOV!N@==T)"HIIIB0O6H<"EW-QN8)(?:A>7O./Q3@@2U.?' F<\J/+9_G'AA
MRBX[YDJR].IM?M<,&4C'G,/F@$A9@[CXJ-:3!W<#,+;O43(E:G(^ _6)C=)S
M:MI>FU@,=Q$!&0?-0UKX(I:&/Z\O4Z-3ZHZE'$TZJ]6KU<=33@YS+S#B#AF4
M6M++&.)CBK(G:BL;<1$3''U'XZX%6F4O::JII'SD<ALO<9^&;/(>&[[8,;V8
MV8*9#O;'7EVY)48-XWE7+V-0.X163!%\HU(50-@$H!Z#MKJ;;;Q3RZ#0A3%-
M@+H^<;"&#*AS1A^1C'-U 4QS"Y2L6.5U?NEVTJ4Y$L)DZ[BK2$*BYF1C8QWW
MG'L'22J*?6<H&Z?3I2C99'&%K@)AAZ2!7IU53S7C]\D5!Y6\/O\ )[*,Q2,3
MFJMCG*;E(SNR(-J=6YF%>-F\?+%EY5=(D=#6R+D63UD#@X"8'/2 B(#KB7EB
M;6X:T@ZG#R]>Y$M2N\FN.]OM,#1ZIF[%UFN-IC#35;K%?NU?F)R<B"-3OCR<
M9&Q[YPZ>,4V:8J&5(42%(&XCMK4F<+=P9-5KCD*%1-D^<[,>4L*<%Y2]X<OU
MAQM<&^:<4QJ-FK+\(V6)&R,F^),,B.CH',FU?-VX%-L7<P '28H^NO>S%9?/
MZ434]KQAY5L.</ZWSXKOD.L-NA&&+J?FV8Q[9G$XJE]J3[&N.R,BA+DDHN5[
M*<B=1PV."/NB; D/6(Z[4IL_32E,*TP)H#X?&2M"GW>#O/*MYZX/4?EIG*9J
MF("':S\/DIW.RZ,%482RTFP2%6F'#5_,F:%2:2KIB"Z1-S (GZ4Q,781XSHR
M]](07-X(4I7"/+SC'R1-+I8)SCCK*#N!*528CJI8&KZ78(& H@[6AS"E*>QW
M-T]\J(H@?<HFZ@$-22"6$5D:0%%L&8>2&!< QK*5S3EVA8R9RFX19K=8F$2Y
MDMNGJ&.8K*>_?%)U!U"DD<"_/;6=I:7%],VWM&E\SL@*"O?1%'ZLO)YAE;SP
M\16>'LYNKI@FV86>/CQM+NS]]CJ=?DH>:5TSN(V-=_2'$FC*QK90Z:Q!52,D
M43 7??6S=[1N-@'F[B+!&:.J1A6O(FN1R2A3\N4^6/&;!B[6'R_G7&.-Y9;M
M(IP]JMT9%R_YP$A%!C%U_J)&QNG<JQDP2,78W5L(".LRVG>QLS6$Q.- >!5Z
MJ/@RY:,[+Y_X4U5SN>=XY2.%'4ZLO"WYX]Q,*$3@E[,NY-TDU?J5E 8Z0;J+
M.%#E(*2A#&4$!#?6[+M6XP0B66)S8SD33'ZJ*2+B?.N%LZ0KRPX6RK0,JP,;
M(%B7\M0+7#6M@PDCMDW:3!ZYAGCQ-JZ4:*E4*102F,0=PW#7-E8^'^4%M42.
MN:>=<?9 X[\N,2X3Y4U"BY[QWB.ZSTW]C6-A8,BX^"K(MGLFC(UJ">*V6&7D
MMR1AE4R)NVRCXHI?J](:]HX) YCWM/M..? HDK\%N5%*X<<,./-:\@O*Z#B<
MS9!B#7F+A,G6B1FLB0-*NCLTK3(6S@9&0LA$HN,6("KV2*1)!10R!EA!,-O6
MZLY)Y/\ $82UI%3D.N:J>AJ5OJM]KD+;Z38H:V56QQ[>6@;%7I%K+0LO&NB
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M1'ZBY:R$!.PTHBQD0(=95@Z]VW]T<3IBF4XE#J0;E%"SVY8VO/4#Y<,T3@G
M+@Q0. &#RX<HL_,V]>4GWMPN5PG&S1@]LEID&K%@JZ1BV(F;Q,8TCXU!!LV
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E/3T^FVHW77[J+[).K;\WXCM\=]OX[_/^FAI7!#T5^HB-$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>drr0676_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0676_ex99-1img02.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X00A:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 Y+C$M8S P,B W.2YA-F$V,SDV.&$L(#(P,C0O,#,O
M,#8M,3$Z-3(Z,#4@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@
M>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X
M;6QN<SIX;7 ](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM<$U-
M.D1O8W5M96YT240](GAM<"YD:60Z.#4V0T,X-S8W1C$R,3%%1CE"14-%0S8W
M,T8Y.4$W0C(B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z.#4V0T,X-S4W
M1C$R,3%%1CE"14-%0S8W,T8Y.4$W0C(B('AM<#I#<F5A=&]R5&]O;#TB061O
M8F4@4&AO=&]S:&]P(#(P,C0@5VEN9&]W<R(^(#QX;7!-33I$97)I=F5D1G)O
M;2!S=%)E9CII;G-T86YC94E$/2)U=6ED.C=A,31D861D+68U,#,M-#5F,RUA
M9F8W+38R9# Y8C4Q.3EF,2(@<W12968Z9&]C=6UE;G1)1#TB=75I9#HX8C8V
M86(S-"TT.#DX+30P9#0M8F9D-"UD,#5B,&1B-C8T.38B+SX@/&1C.F-R96%T
M;W(^(#QR9&8Z4V5Q/B \<F1F.FQI/DUI;FD@4&%T;FD\+W)D9CIL:3X@/"]R
M9&8Z4V5Q/B \+V1C.F-R96%T;W(^(#QD8SIT:71L93X@/')D9CI!;'0^(#QR
M9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!3
M15]I;G1I;6%T:6]N7U)E9S,P7TY3/"]R9&8Z;&D^(#PO<F1F.D%L=#X@/"]D
M8SIT:71L93X@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM
M<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X
M0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E       0_.$?B<BW
MR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_VP"$  $! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @(" @(" @,# P,#
M P,# P,! 0$! 0$! @$! @(" 0(" P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# __  !$( #  E0,!$0 "$0$#$0'_
MQ "7   !! ,! 0$             !@<("0,$!0$* @$!  ,! 0$
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M#=U(2T14<[DZ!7[W"PW1KFY$JSQXQ1<.JP_5D<Q&OHRB1W[U=%VDJ!#DD2%
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$X!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
